Renvela^® (Sevelamer Carbonate)

Bibliographical Information:

Drug Name	Generic Name	Studied Indications or Disease	Approved U.S. Drug Label
Renvela®	Sevelamer Carbonate	chronic kidney disease	Prescribing Info

Protocol SVCARB00105

Ketteler M, Rix M, Fan S, Pritchard N, Oestergaard O, Chasan-Taber S, Heaton J, Duggal A, Kalra PA. Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic CKD patients not on dialysis. Clin J Am Soc Nephrol e-published May 1, 2008

Protocol SVCARB00205

No associated publications.

Protocol GD3-163-201

Delmez J, Block G, Robertson J, Chasan-Taber S, Blair A, Dillon M, et al. A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. Clin Nephrol. 2007;68(6):386-391

Protocol GD3-199-301

No associated publications.